TobraDex ST available for ocular inflammation and infection

TOBRADEX ST (tobramycin/dexamethasone) 0.3%/0.05% ophthalmic suspension by Alcon
TOBRADEX ST (tobramycin/dexamethasone) 0.3%/0.05% ophthalmic suspension by Alcon
Alcon announced that TobraDex ST (tobramycin and dexamethasone ophthalmic suspension) has been made available for the treatment of steroid-responsive inflammatory ocular conditions where superficial bacterial ocular infection or risk of infection exists. TobraDex ST, a topical antibiotic and corticosteroid combination, is available in a tobramycin/dexamethasone 0.3%/0.05% strength.

For more information call (800) 757-9195 or visit www.alcon.com.